Novel strategy of gene therapy in cardiovascular disease with HVJ-liposome method

Contributions to Nephrology

Volumn 118, Issue , 1996, Pages 254-264

  Morishita, Ryuichi ^a   Higaki, Jitsuo ^a   Aoki, Motokuni ^a   Hayashi, Shin Ichiro ^a   Kida, Iwao ^a   Kaneda, Yasufumi ^b   Ogihara, Toshio ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOSOME;

CARDIOVASCULAR DISEASE; GENE THERAPY; GENETICS; HUMAN; KIDNEY DISEASE; PARAINFLUENZA VIRUS 1; REVIEW;

CARDIOVASCULAR DISEASES; GENE THERAPY; HUMANS; KIDNEY DISEASES; LIPOSOMES; PARAINFLUENZA VIRUS 1, HUMAN;

EID: 0029689801     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (26)

1. Thompson L: At age 2, gene therapy enters a growth phase. Science 1992;258:744-746.
2. Miller AD: Human gene therapy comes of age. Nature 1992;357:455-460.
3. Anderson WA: Human gene therapy. Science 1992;256:808-813.
4. Dzau VJ, Gibbons GH, Cooke JP, Omoigui N: Vascular biology and medicine in the 1990s: Scope, concepts, potential, and perspectives. Circulation 1993;87:705-719.
5. Felgner PL, Rhodes G: Gene therapeutics. Nature 1991;349:351-352.
6. Nabel EG, Nabel GJ: Gene transfer and cardiovascular diseases. TCM 1991;Jan/Feb:12-17.
7. Dzau VJ, Morishita R, Gibbons GH: Gene therapy in the cardiovascular diseases. Trends Biotechnol 1993;11:205-210.
8. Kaneda Y, Iwai K, Uchida T: Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science 1989;243:375-378.
9. Tomita N, Higaki J, Morishita R, Kato K, Mikami H, Kaneda Y, Ogihara T: Direct in vivo gene introduction into rat kidney. Biochem Biophys Res Commun 1992;186:129-134.
10. Morishita R, Gibbons GH, Ellison KE, Nakajima M, Zhang L, Kaneda Y, Ogihara T, Dzau VJ: Single intraluminal delivery of antisense cdc 2 kinase and PCNA oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc Natl Acad Sci USA 1993;90:8474-8478.
11. Morishita R, Gibbons GH, Ellison KE, Horiuchi M, Nakajima M, Zhang L, Kaneda Y, Ogihara T, Dzau VJ: A novel molecular strategy using cis element 'decoy' of E2F binding site inhibits smooth muscle proliferation in vivo. Proc Natl Acad Sci USA 1995:5855-5859.
12. Morishita R, Gibbons GH, Ellison KE, Lee W, Zhang L, Kaneda Y, Ogihara T, Dzau VJ: Evidence for direct local effect of angiotensin in vascular hypertrophy: In vivo gene transfer of angiotensin converting enzyme. J Clin Invest 1994;94:978-984.
13. Morishita R, Gibbons GH, Dzau VJ: Analysis of cellular uptake of antisense oligonucleotides using FITC-labeled oligonucleotides. Oligotechniques 1994;2:1-3.
14. Lim CS, Chapman GD, Gammon RS, Muhlestein JB, Bauman RP, Stack RS, Swain JL: Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog. Circulation 1991;83:2007-2011.
15. Simons M, Edelman ER, Dekeyser JL, Langer R, Rosenberg RD: Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature 1992;359:67-70.
16. Morishita R, Gibbons GH, Ellison KE, Nakajima M, Leyen HVL, Zhang L, Kaneda Y, Ogihara T, Dzau VJ: Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J Clin Invest 1994;93:1458-1464.
17. Morishita R, Gibbons GH, Ellison KE, Nakajima M, Leyen HVL, Zhang L, Kaneda Y, Ogihara T, Dzau VJ: Antisense oligonucleotides directed at cell cycle regulatory genes as a target for restenosis therapy. Trans Assoc Am Physicians 1993;106:54-61.
18. 1 and cdc 2 kinase) in the vessel wall: Enhanced therapeutic utility for restenosis by HVJ-liposome method. Gene 1994;149:13-19.
19. Wilson JM, Birinyi LK, Salomon RN, Libby P, Callow AD, Mulligan RC: Implication of vascular grafts lined with genetically modified endothelial cells. Science 1989;244:1344-1346.
20. Nabel EG, Plautz G, Boyce FM, Stanley JC, Nabel GJ: Recombinant gene expression in vivo within endothelial cells of the arterial wall. Science 1989;244:1342-1344.
21. Morishita R, Gibbons GH, Kaneda Y, Ogihara T, Dzau VJ: In vivo gene transfer into intact blood vessels: A novel and efficient method (abstract). Circulation 1992;86:1-227.
22. Leyen HVL, Gibbons GH, Morishita R, Lewis NP, Zhang L, Nakajima M, Kaneda Y, Cooke JP, Dzau VJ: Gene therapy inhibiting neointimal vascular lesion: In vivo transfer of EC-nitric oxide synthase gene. Proc Natl Acad Sci USA 1995;92:1137-1141.
23. Nakajima M, Horiuchi M, Morishita R, Yamada T, Pratt RE, Dzau VJ: Growth inhibitory function of type 2 angiotensin II receptor: Gain of function study by in vivo gene transfer. Hypertension 1994;24:379.
24. Ohno T, Gordon D, San H, Pompili VJ, Imperiale MJ, Nabel GJ, Nabel EG: Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science 1994;265:781-784.
25. Seltzer J, Chang M, Barr E, Parmacek MS, Leiden JM: Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by a replication-defective adenovirus encoding a non-phosphorylatable retinoblastoma gene product. Circulation 1994;90:1-90.
26. Koseki C, Herzlinger D, AI-Awqati: Integration of embryonic nephrogenic cells carrying a reporter gene into functioning nephrons. Am J Physiol 1991;261:C550-C554.